{"paper_id":"44f3980b-c8e9-4775-b708-0e06001741c3","body_text":"Abstract\nMany pain conditions in patients tend to co-occur, influencing the clinical expressions of each other in various ways. This paper summarizes the main concurrent pain conditions by analyzing the major interactions observed. In particular, co-occurrence will be examined in: visceral pain (especially ischemic heart disease, irritable bowel syndrome, dysmenorrhea/endometriosis and urinary pain), fibromyalgia, musculoskeletal pain and headache. Two concurrent visceral pains from internal organs sharing at least part of their central sensory projection can give rise to viscero-visceral hyperalgesia, i.e., enhancement of typical pain symptoms from both districts. Visceral pain, headache and musculoskeletal pains (myofascial pain from trigger points, joint pain) can enhance pain and hyperalgesia from fibromyalgia. Myofascial pain from trigger points can perpetuate pain symptoms from visceral pain conditions and trigger migraine attacks when located in the referred pain area from an internal organ or in cervico-facial areas, respectively. The pathophysiology of these pain associations is complex and probably multifactorial; among the possible processes underlying the mutual influence of symptoms recorded in the associations is modulation of central sensitization phenomena by nociceptive inputs from one or the other condition. A strong message in these pain syndrome co-occurrence is that effective treatment of one of the conditions can also improve symptoms from the other, thus suggesting a systematic and thorough evaluation of the pain patient for a global effective management of his/her suffering.\nSimilar content being viewed by others\nReferences\nAamodt AH, Stovner LJ, Hagen K, Zwart JA (2008) Comorbidity of headache and gastrointestinal complaints. Head HUNT Study. Cephalalgia 28:144–151\nAdelborg K, Szépligeti SK, Holland-Bill L, Ehrenstein V, Horváth-Puhó E, Henderson VW, Sørensen HT (2018) Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ 360:k96\nAffaitati G, Vecchiet F, Lerza R, De Laurentis S, Iezzi S, Festa F, Giamberardino MA (2001) Effects of topical diclofenac (DHEP plaster) on skin, subcutis and muscle pain thresholds in subjects without spontaneous pain. Drugs Exp Clin Res 27(2):69–76\nAffaitati G, Giamberardino MA, Lerza R, Lapenna D, De Laurentis S, Vecchiet L (2002) Effects of tramadol on behavioural indicators of colic pain in a rat model of ureteral calculosis. Fundam Clin Pharmacol 16(1):23–30\nAffaitati G, Fabrizio A, Savini A, Lerza R, Tafuri E, Costantini R, Lapenna D, Giamberardino MA (2009) A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther 31(4):705–720\nAffaitati G, Costantini R, Fabrizio A, Lapenna D, Tafuri E, Giamberardino MA (2011) Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain 15:61–69\nAffaitati G, Fabrizio A, Frangione V, Lanzarotti A, Lopopolo M, Tafuri E, Lapenna D, Giamberardino MA, Costantini R (2015) Effects of topical diclofenac plus heparin (DHEP + H plaster) on somatic pain sensitivity in healthy subjects with a latent algogenic condition of the lower limb. Pain Pract 15(1):58–67\nAffaitati G, Martelletti P, Lopopolo M, Tana C, Massimini F, Cipollone F, Lapenna D, Giamberardino MA, Costantini R (2017) Use of nonsteroidal anti-inflammatory drugs for symptomatic treatment of episodic headache. Pain Pract 17(3):392–401\nAffaitati G, Costantini R, Tana C, Lapenna D, Schiavone C, Cipollone F, Giamberardino MA (2018a) Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis. J Headache Pain 19(1):104\nAffaitati G, Giamberardino MA, Lapenna D, Costantini R (2018b) Diclofenac epolamine topical patch for the treatment of pain. J Biol Regul Homeost Agents 32(3):435–441\nAlabousi A, Patlas MN, Mellnick VM, Chernyak V, Farshait N, Katz DS (2019) Renal colic imaging: myths, recent trends, and controversies. Can Assoc Radiol J 70(2):164–171\nAloisi AM, Affaitati G, Ceccarelli I, Fiorenzani P, Lerza R, Rossi C, Pace MC, Chiefari M, Aurilio C, Giamberardino MA (2010) Estradiol and testosterone differently affect visceral pain-related behavioural responses in male and female rats. Eur J Pain 14(6):602–607\nAlonso-Blanco C, Fernández-de-las-Peñas C, Morales-Cabezas M, Zarco-Moreno P, Ge HY, Florez-García M (2011) Multiple active myofascial trigger points reproduce the overall spontaneous pain pattern in women with fibromyalgia and are related to widespread mechanical hypersensitivity. Clin J Pain 27(5):405–413\nAltman G, Cain KC, Motzer S, Jarrett M, Burr R, Heitkemper M (2006) Increased symptoms in female IBS patients with dysmenorrhea and PMS. Gastroenterol Nurs 29:4–11\nAlvarez DJ, Rockwell PG (2002) Trigger points: diagnosis and management. Am Fam Physician 65:653–660\nAmerican Headache Society (2019) The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache 59:1–18\nAmmons WS, Blair RW, Foreman RD (1984) Responses of primate T1–T5 spinothalamic neurons to gallbladder distension. Am J Physiol 247:995–1002\nArendt-Nielsen L, Schipper KP, Dimcevski G, Sumikura H, Krarup AL, Giamberardino MA, Drewes AM (2008) Viscero-somatic reflexes in referred pain areas evoked by capsaicin stimulation of the human gut. Eur J Pain 12(5):544–551\nAziz Q, Giamberardino MA (2017) Visceral pain comorbidity in headache. In: Martelletti P, Giamberardino MA (eds) Comorbidities in headache disorders. Springer International Publishing, Switzerland, pp 65–84\nAziz Q, Giamberardino MA, Barke A, Korwisi B, Baranowski AP, Wesselmann U, Rief W, Treede RD (2019) IASP Taskforce for the Classification of Chronic Pain The IASP classification of chronic pain for ICD-11: chronic secondary visceral pain. Pain 160(1):69–76\nBajaj P, Bajaj P, Madsen H, Arendt-Nielsen L (2003) Endometriosis is associated with central sensitization: a psychophysical controlled study. J Pain 4(7):372–380\nBaranowski AP (2009) Chronic pelvic pain. Best Pract Res Clin Gastroenterol 23:593–610\nBartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Brighina F, Fierro B (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain 12(3):361–368\nBerkley KJ (2005) A life of pelvic pain. Physiol Behav 86:272–280\nBerkley KJ, Cason A, Jacobs H, Bradshaw HB, Wood E (2001) Vaginal hyperalgesia in a rat model of endometriosis. Neurosci Lett 306:185–188\nBezov D, Ashina S, Jensen R, Bendtsen L (2011) Pain perception studies in tension-type headache. Headache 51:262–271\nBigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB (2010) Migraine and cardiovascular disease: a population-based study. Neurology 4(8):628–635\nBonica JJ (ed) (1990) The management of pain, 2nd edn. Lea & Febiger, Philadephia\nBrinkert W, Dimcevski G, Arendt-Nielsen L, Drewes AM, Wilder-Smith OH (2007) Dysmenorrhoea is associated with hypersensitivity in the sigmoid colon and rectum. Pain 132:S46–S51\nBrumovsky PR, Gebhart GF (2010) Visceral organ cross-sensitization: an integrated perspective. Auton Neurosci 153:106–115\nCabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata JL (2017) Fibromyalgia: prevalence, epidemiologic profiles and economic costs. Med Clin (Barc) 149:441–448\nCakit BD, Taskin S, Nacir B, Unlu I, Genc H, Erdem HR (2010) Comorbidity of fibromyalgia and cervical myofascial pain. Clin Rheumatol 29:405–411\nCaldarella MP, Giamberardino MA, Sacco F, Affaitati G, Milano A, Lerza R, Balatsinou C, Laterza F, Pierdomenico SD, Cuccurullo F, Neri M (2006) Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 101(12):2782–2789\nCassisi G, Sarzi-Puttini P, Alciati A, Casale R, Bazzichi L, Carignola R, Gracely RH, Salaffi F, Marinangeli F, Torta R, Giamberardino MA, Buskila D, Spath M, Cazzola M, Di Franco M, Biasi G, Stisi S, Altomonte L, Arioli G, Leardini G, Gorla R, Marsico A, Ceccherelli F, Atzeni F, Network Italian Fibromyalgia (2008) Symptoms and signs in fibromyalgia syndrome. Reumatismo 60(Suppl 1):15–24\nCastro Sánchez AM, García López H, Fernández Sánchez M, Pérez Mármol JM, Aguilar-Ferrándiz ME, Luque Suárez A, Matarán Peñarrocha GA (2009) Improvement in clinical outcomes after dry needling versus myofascial release on pain pressure thresholds, quality of life, fatigue, pain intensity, quality of sleep, anxiety, and depression in patients with fibromyalgia syndrome. Disabil Rehabil 41(19):2235–2246\nCentonze V, Polito BM, Cassiano MA, Doronzo F, Ricchetti G, Portincasa P, Bassi A, Albano O (1996) The dyspeptic syndrome in migraine: morphofunctional evaluation on 53 patients. Headache 36:442–445\nCervero F (2000) Visceral pain-central sensitization. Gut 47:56–57\nCervero F, Laird JM (2004) Understanding the signaling and transmission of visceral nociceptive events. J Neurobiol 61:45–54\nChaban VV (2008) Visceral sensory neurons that innervate both uterus and colon express nociceptive TRPV1 and P2X3 receptors in rats. Ethn Dis 18:S220–S224\nChaban V, Christensen A, Wakamatsu M, McDonald M, Rapkin A, McDonald J, Micevych P (2007) The same dorsal root ganglion neurons innervate uterus and colon in the rat. NeuroReport 18:209–212\nCho S-J, Sohn J-H, Bae JS, Chu MK (2017) Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: a Multicenter Prospective Cross-Sectional Study. Headache 57:1583–1592\nChung MK, Chung RP, Gordon D (2005) Interstitial cystitis and endometriosis in patients with chronic pelvic pain: the “Evil Twins” syndrome. JSLS 9(1):25–29\nCole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA (2006) Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol 6:26\nColson NJ, Lea RA, Quinlan S, Griffiths LR (2006) No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. BMC Med Genet 7:12\nCoppola G, Di Lorenzo C, Schoenen J, Pierelli F (2013) Habituation and sensitization in primary headaches. J Headache Pain 14:65\nCostantini R, Di Bartolomeo N, Francomano F, Angelucci D, Innocenti P (2005a) Epithelioid angiosarcoma of the gallbladder: case report. J Gastrointest Surg 9(6):822–825\nCostantini R, Sardellone A, Marino C, Giamberardino MA, Innocenti P, Napolitano AM (2005b) Vacuum-assisted core biopsy (Mammotome) for the diagnosis of non-palpable breast lesions: four-year experience in an Italian center. Tumori 91(4):351–354\nCostantini R, De Nicola P, Bianco F, Cotroneo AR, Iezzi R, Di Bartolomeo N, Innocenti P (2007) Tumor vs non-tumor origin of occult and obscure gastrointestinal bleeding requiring hospitalization. Tumori 93(5):461–466\nCostantini R, Affaitati G, Fabrizio A, Giamberardino MA (2011) Controlling pain in the post-operative setting. Int J Clin Pharmacol Ther 49(2):116–127\nCostantini R, Caldaralo F, Palmieri C, Napolitano L, Aceto L, Cellini C, Innocenti P (2012) Risk factors for conversion of laparoscopic cholecystectomy. Ann Ital Chir 83(3):245–252\nCostantini R, Affaitati G, Massimini F, Tana C, Innocenti P, Giamberardino MA (2016) Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization. PLoS ONE 11(4):e0153408. https://doi.org/10.1371/journal.pone.0153408\nCostantini R, Affaitati G, Wesselmann U, Czakanski P, Giamberardino MA (2017) Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients. Pain 158(10):1925–1937\nCouppe C, Midttun A, Hilden J, Jorgensen U, Oxholm P, Fuglsang-Frederiksen A (2001) Spontaneous needle electromyographic activity in myofascial trigger points in the infraspinatus muscle: a blinded assessment. J Musculoske Pain 9:7–16\nCummings M (2007) Regional myofascial pain: diagnosis and management. Best Pract Res Clin Rheumatol 21(2):367–387\nDahan A, van Velzen M, Niesters M (2014) Comorbidities and the complexities of chronic pain. Anesthesiology 121(4):675–677\nde Tommaso M (2012) Prevalence, clinical features and potential therapies for fibromyalgia in primary headaches. Expert Rev Neurother 12:287–295\nde Tommaso M, Sardaro M, Vecchio E, Serpino C, Stasi M, Ranieri M (2008) Central sensitisation phenomena in primary headaches: overview of a preventive therapeutic approach. CNS Neurol Disord: Drug Targets 7:524–535\nde Tommaso M, Sardaro M, Serpino C, Costantini F, Vecchio E, Prudenzano MP, Lamberti P, Livrea P (2009) Fibromyalgia comorbidity in primary headaches. Cephalalgia 29:453–464\nde Tommaso M, Federici A, Loiacono A, Delussi M, Todarello O (2014) Personality profiles and coping styles in migraine patients with fibromyalgia comorbidity. Compr Psychiatry 55:80–86\nDimitrova AK, Ungaro RC, Lebwohl B, Lewis SK, Tennyson CA, Green MW, Babyatsky MW, Green PH (2013) Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache 53:344–355\nDo TP, Heldarskard GF, Kolding LT, Hvedstrup J, Schytz HW (2018) Myofascial trigger points in migraine and tension-type headache. J Headache Pain 19(1):84\nDommerholt J, Hooks T, Chou LW, Finnegan M (2019) A critical overview of the current myofascial pain literature - November 2018. J Bodyw Mov Ther 23(1):65–73\nDrewes AM, Jennum P (1995) Epidemiology of myofascial pain, low back pain, morning stiffness and sleep-related complaints in the general population. J Musculoske Pain 3(1):121\nDuffield SJ, Ellis BM, Goodson N, Walker-Bone K, Conaghan PG, Margham T, Loftis T (2017) The contribution of musculoskeletal disorders in multimorbidity: implications for practice and policy. Best Pract Res Clin Rheumatol 31(2):129–144\nEvans SF, Brooks TA, Esterman AJ, Hull ML, Rolan PE (2018) The comorbidities of dysmenorrhea: a clinical survey comparing symptom profile in women with and without endometriosis. J Pain Res 11:3181–3194\nFan YH, Lin AT, Lu SH, Chuang YC, Chen KK (2014) Non-bladder conditions in female Taiwanese patients with interstitial cystitis/hypersensitive bladder syndrome. Int J Urol 21(8):805–809\nFariello JY, Moldwin RM (2015) Similarities between interstitial cystitis/bladder pain syndrome and vulvodynia: implications for patient management. Transl Androl Urol 4(6):643–652\nFernández-de-Las-Peñas C, Dommerholt J (2018) International Consensus on Diagnostic Criteria and Clinical Considerations of Myofascial Trigger Points: a Delphi Study. Pain Med 19(1):142–150\nFernández-de-Las-Peñas C, Ge HY, Alonso-Blanco C, Gonzalez-Iglesias J, Arendt-Nielsen L (2010) Referred pain areas of active myofascial trigger points in head, neck and shoulder muscles, in chronic tension type headache. J Bodyw Mov Ther 14:391–396\nFerrero S, Pretta S, Bertoldi S, Anserini P, Remorgida V, Del Sette M, Gandolfo C, Ragni N (2004) Increased frequency of migraine among women with endometriosis. Hum Reprod 19(12):2927–2932\nFesti D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, Pazzi P, Gazzella G, Sama C, Roda E, Colecchia A (2008) Incidence of gallstone disease in Italy: results from a multicenter, population based Italian study (the MICOL project). World J Gastroenterol 14:5282–5289\nFilatova E, Latysheva N, Kurenkov A (2008) Evidence of persistent central sensitization in chronic headaches: a multi-method study. J Headache Pain 9:295–300\nFrøkjaer JB, Andersen SD, Gale J, Arendt-Nielsen L, Gregersen H, Drewes AM (2005) An experimental study of viscero-visceral hyperalgesia using an ultrasound-based multimodal sensory testing approach. Pain 119:191–200\nGarcía-Leiva JM, Hidalgo J, Rico-Villademoros F, Moreno V, Calandre EP (2007) Effectiveness of ropivacaine trigger points inactivation in the prophylactic management of patients with severe migraine. Pain Med 8(1):65–70\nGe HY, Nie H, Madeleine P, Danneskiold-Samsøe B, Graven-Nielsen T, Arendt-Nielsen L (2009) Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome. Pain 147:233–240\nGe HY, Wang Y, Fernández-de-las-Peñas C, Graven-Nielsen T, Danneskiold-Samsøe B, Arendt-Nielsen L (2011) Reproduction of overall spontaneous pain pattern by manual stimulation of active myofascial trigger points in fibromyalgia patients. Arthritis Res Ther 13(2):R48\nGebhart GF, Bielefeldt K (2016) Physiology of Visceral Pain. Compr Physiol 6(4):1609–1633\nGeorgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, Lolis D (1999) Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1:164–166\nGerwin RD (1999) Myofascial pain syndromes from trigger points. Curr Rev Pain 3:153–159\nGerwin RD (2001) Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep 5:412–420\nGerwin RD (2016) Myofascial Trigger Point Pain Syndromes. Semin Neurol 36(5):469–473\nGiamberardino MA (2008) Women and visceral pain: are the reproductive organs the main protagonists? Mini-review at the occasion of the “European Week Against Pain in Women 2007”. Eur J Pain 12(3):257–260\nGiamberardino MA, Costantini R (2017) Challenging chronic migraine: targeting the CGRP receptor. Lancet Neurol 16(6):410–411\nGiamberardino MA, Jensen T (eds) (2012) Pain comorbidities: understanding and treating the complex patient. IASP Press, Seattle, pp 1–518\nGiamberardino MA, Martelletti P (2015) Emerging drugs for migraine treatment. Expert Opin Emerg Drugs 20(1):137–147\nGiamberardino MA, Vecchiet L (1995) Visceral pain, referred hyperalgesia and outcome: new concepts. Eur J Anaesthesiol Suppl 10:61–66\nGiamberardino MA, de Bigontina P, Martegiani C, Vecchiet L (1994) Effects of extracorporeal shock-wave lithotripsy on referred hyperalgesia from renal/ureteral calculosis. Pain 56:77–83\nGiamberardino MA, Dragani L, Valente R, Di Lisa F, Saggini R, Vecchiet L (1996) Effects of prolonged L-carnitine administration on delayed muscle pain and CK release after eccentric effort. Int J Sports Med 17(5):320–324\nGiamberardino MA, Berkley KJ, Iezzi S, de Bigontina P, Vecchiet L (1997) Pain threshold variations in somatic wall tissues as a function of menstrual cycle, segmental site and tissue depth in non-dysmenorrheic women, dysmenorrheic women and men. Pain 71(2):187–197\nGiamberardino MA, De Laurentis S, Affaitati G, Lerza R, Lapenna D, Vecchiet L (2001) Modulation of pain and hyperalgesia from the urinary tract by algogenic conditions of the reproductive organs in women. Neurosci Lett 304:61–64\nGiamberardino MA, Berkley KJ, Affaitati G, Lerza R, Centurione L, Lapenna D, Vecchiet L (2002) Influence of endometriosis on pain behaviors and muscle hyperalgesia induced by a ureteral calculosis in female rats. Pain 95(3):247–257\nGiamberardino MA, Affaitati G, Lerza R, Lapenna D, Costantini R, Vecchiet L (2005) Relationship between pain symptoms and referred sensory and trophic changes in patients with gallbladder pathology. Pain 114(1–2):239–249\nGiamberardino MA, Affaitati G, Costantini R (2006) Chapter 24. Referred pain from internal organs. Handbook of Clinical Neurology 81:343–361\nGiamberardino MA, Tafuri E, Savini A, Fabrizio A, Affaitati G, Lerza R, Di Ianni L, Lapenna D, Mezzetti A (2007) Contribution of myofascial trigger points to migraine symptoms. J Pain 8(11):869–878\nGiamberardino MA, Affaitati G, Costantini R (2010a) Visceral referred pain. J Musculoske. Pain 18:403–410\nGiamberardino MA, Costantini R, Affaitati G, Fabrizio A, Lapenna D, Tafuri E, Mezzetti A (2010b) Viscero-visceral hyperalgesia: characterization in different clinical models. Pain 151(2):307–322\nGiamberardino MA, Affaitati G, Fabrizio A, Costantini R (2011a) Effects of treatment of myofascial trigger points on the pain of fibromyalgia. Curr Pain Headache Rep 15(5):393–399\nGiamberardino MA, Affaitati G, Fabrizio A, Costantini R (2011b) Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol 25(2):185–198\nGiamberardino MA, Affaitati G, Costantini R (2012) Concurrent visceral pain syndromes: the concept of viscero-visceral hyperalgesia. In: Giamberardino MA, Jensen TS (eds) Pain comorbidities: Understanding and treating the complex patient. IASP Press, Seattle, pp 309–330\nGiamberardino MA, Tana C, Costantini R (2014) Pain thresholds in women with chronic pelvic pain. Curr Opin Obstet Gynecol 26(4):253–259\nGiamberardino MA, Affaitati G, Martelletti P, Tana C, Negro A, Lapenna D, Curto M, Schiavone C, Stellin L, Cipollone F, Costantini R (2015) Impact of migraine on fibromyalgia symptoms. J Headache Pain. 17:28\nGiamberardino MA, Affaitati G, Curto M, Negro A, Costantini R, Martelletti P (2016) Anti-CGRP monoclonal antibodies in migraine: current perspectives. Intern Emerg Med 11(8):1045–1057\nGiamberardino MA, Affaitati G, Costantini R, Cipollone F, Martelletti P (2017) Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab. J Pain Res 10:2751–2760\nGraff-Radford SB (2004) Myofascial pain: diagnosis and management. Curr Pain Headache Rep 8:463–467\nGrayston R, Czanner G, Elhadd K, Goebel A, Frank B, Üçeyler N, Malik RA, Alam U (2019) A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: implications for a new paradigm in fibromyalgia etiopathogenesis. Semin Arthritis Rheum 48:933–940\nGraziano E, Hagemeier J, Weinstock-Guttman B, Ramasamy DP, Zivadinov R (2015) Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients. NeuroImage Clin 9:110–116\nGreenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC Jr, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL et al (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 56(25):e50–e103\nHalder SLS, Locke GR III (2009) Epidemiology and social impact of visceral pain. In: Giamberardino MA (ed) Visceral pain:clinical, pathophysiological and therapeutic aspects. Oxford University Press, Oxford, pp 1–8\nHäuser W, Marschall U, Layer P, Grobe T (2019) The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome. Dtsch Arztebl Int 116(27–28):463–470\nHeadache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211\nHeidari F, Afshari M, Moosazadeh M (2017) Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int 37:1527–1539\nHeitkemper MM, Jarrett ME (2008) Update on irritable bowel syndrome and gender differences. Nutr Clin Pract 23:275–283\nHejazi RA, McCallum RW (2011) Review article: cyclic vomiting syndrome in adults: rediscovering and redefining an old entity. Aliment Pharmacol Ther 4:263–273\nHong C-Z, Chen Y-N, Twehous DA, Hong D (1996) Pressure threshold for referred pain by compression on the trigger point and adjacent areas. J Musculoske Pain 4:61–79\nHoughton LA, Lea R, Jackson N, Whorwell PJ (2002) The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 50:471–474\nIacovides S, Avidon I, Baker FC (2015) What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 21(6):762–778\nIuvone T, Affaitati G, De Filippis D, Lopopolo M, Grassia G, Lapenna D, Negro L, Costantini R, Vaia M, Cipollone F, Ialenti A, Giamberardino MA (2016) Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: role of mast cells. Pain 157(1):80–91\nJarrell J, Giamberardino MA, Robert M, Nasr-Esfahani M (2011) Bedside testing for chronic pelvic pain: discriminating visceral from somatic pain. Pain Res Treat 2011:692102\nJarrell J, Ross S, Robert M, Wood S, Tang S, Stephanson K, Giamberardino MA (2014) Prediction of postoperative pain after gynecologic laparoscopy for nonacute pelvic pain. Am J Obstet Gynecol 211(4):360.e1–360.e8\nJohnson CM, Makai GEH (2018) Fibromyalgia and Irritable Bowel Syndrome in Female Pelvic Pain. Semin Reprod Med 36(2):136–142\nKahriman A, Zhu S (2018) Migraine and Tension-Type Headache. Semin Neurol 38(6):608–618\nKato K, Sullivan PF, Evengard B, Pedersen NL (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166:1649–1654\nKatz VL (2007) Endometriosis. In: Katz VL (ed) Comprehensive gynecology, 5th edn. Philadelphia, Mosby Elsevier, MD Consult\nKaunisto MA, Kallela M, Hamalainen E, Kilpikari R, Havanka H, Harno H, Nissilä M, Säkö E, Ilmavirta M, Liukkonen J, Teirmaa H, Törnwall O, Jussila M, Terwilliger J, Färkkilä M, Kaprio J, Palotie A, Wessman M (2006) Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 26(12):1462–1472\nKim HJ (2016) Update on the pathology and diagnosis of interstitial cystitis/bladder pain syndrome: a review. Int Neurourol J 20(1):13–17\nKim SH, Choi YM, Jun JK, Kim JG, Moon SY (2005) Estrogen receptor dinucleotide repeat polymorphism is associated with minimal or mild endometriosis. Fertil Steril 84(3):774–777\nKuan TS (2009) Current studies on myofascial pain syndrome. Curr Pain Headache Rep 13:365–369\nKüçükşen S, Genç E, Yılmaz H, Sallı A, Gezer İA, Karahan AY, Salbaş E, Cingöz HT, Nas Ö, Uğurlu H (2013) The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol 32:983–990\nKurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (2006) Migraine and risk of cardiovascular disease in women. JAMA 296(3):283–291\nKurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, Buring JE (2007) Migraine and risk of cardiovascular disease in men. Arch Intern Med 167(8):795–801\nKurth T, Diener HC, Buring JE (2011) Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women’s Health Study. Cephalalgia 31(10):1106–1115\nLackner JM, Ma C-X, Keefer LA, Brenner DM, Gudleski GD, Satchidanand N, Firth R, Sitrin MD, Katz L, Krasner SS, Ballou SK, Naliboff BD, Mayer EA (2013) Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 11(9):1147–1157\nLeo MM, Langlois BK, Pare JR, Mitchell P, Linden J, Nelson KP, Amanti C, Carmody KA (2017) Ultrasound vs. computed tomography for severity of hydronephrosis and its importance in renal colic. West J Emerg Med 18(4):559–668\nLi J, Micevych P, McDonald J, Rapkin A, Chaban V (2008) Inflammation in the uterus induces phosphorylated extracellular signal-regulated kinase and substance P immunoreactivity in dorsal root ganglia neurons innervating both uterus and colon in rats. J Neurosci Res 86:2746–2752\nLichtenstein A, Tiosano S, Amital H (2018) The complexities of fibromyalgia and its comorbidities. Curr Opin Rheumatol 30(1):94–100\nLoeser JD (2001) Bonica’s management of pain. Lippincott, Williams & Wilkins, Philadelphia\nLopopolo M, Affaitati G, Fabrizio A, Massimini F, Lapenna D, Giamberardino MA, Costantini R (2014) Effects of tramadol on viscero-visceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis. Fundam Clin Pharmacol 28(3):331–341\nLucas N, Macaskill P, Irwing L, Moran R, Bogduk N (2009) Reliability of physical examination for diagnosis of myofascial trigger points: a systematic review of the literature. Clin J Pain 25:80–89\nMaggioni F, Palmieri A, Tropea M, Zanchin G (2008) Influence of physiologic hormonal modification and of hormonal treatment in a patient with a history of migraine with aura. J Headache Pain 9(2):129–131\nMajlesi J, Unalan H (2010) Effect of treatment on trigger points. Curr Pain Headache Rep 14:353–360\nMalykhina AP (2007) Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 149(3):660–672\nMalykhina AP (2012) Experimental animal models of pain and non-pain comorbidities. In: Giamberardino MA, Jensen TS (eds) Pain comorbidities: Understanding and treating the complex patient. IASP Press, Seattle, pp 37–56\nMalykhina AP, Qin C, Greenwood-van Meerveld B, Foreman RD, Lupu F, Akbarali HI (2006) Hyperexcitability of convergent colon and bladder dorsal root ganglion neurons after colonic inflammation: mechanism for pelvic organ cross-talk. Neurogastroenterol Motil 18:936–948\nMannix LK (2008) Menstrual-related pain conditions: dysmenorrhea and migraine. J Womens Health (Larchmt) 17(5):879–891\nMarcus DA, Bhowmick A (2013) Fibromyalgia comorbidity in a community sample of adults with migraine. Clin Rheumatol 32:1553–1556\nMarjoribanks J, Ayeleke RO, Farquhar C, Proctor M (2015) Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 7:CD001751\nMarson L, Giamberardino MA, Costantini R, Czakanski P, Wesselmann U (2013) Animal models for the study of female sexual dysfunction. Sex Med Rev 1(2):108–122\nMatalliotakis IM, Cakmak H, Fragouli YG, Goumenou AG, Mahutte NG, Arici A (2008) Epidemiological characteristics in women with and without endometriosis in the Yale series. Arch Gynecol Obstet 277(5):389–393\nMense S, Simons DG, Russell IJ (2001) Muscle pain. Understanding its nature, diagnosis, and treatment. Lippincott, Williams & Wilkins, Philadelphia\nMerskey H (2012) Introduction. In: Giamberardino MA, Jensen TS (eds) Pain comorbidities. Understanding and treating the complex patient. IASP Press, Seattle, pp 1–17\nMeucci G, Radaelli F, Prada A, Bortoli A, Crotta S, Cerrato C, Minoli G (2005) Increased prevalence of migraine in patients with uninvestigated dyspepsia referred for open access upper gastrointestinal endoscopy. Endoscopy 37:622–625\nMilligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10:23–36\nMöhrke J, Kropp P, Zettl UK (2013) Headaches in multiple sclerosis patients might imply an inflammatorial process. PLoS One 8:e69570\nMoisset X, Ouchchane L, Guy N, Bayle DJ, Dallel R, Clavelou P (2013) Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis. Pain 154:2691–2699\nMoisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M, Dallel R, Guttmann A, Clavelou P, Buisson A (2017) Migraine prevalence in inflammatory bowel disease patients: a tertiary-care centre cross-sectional study. Eur J Pain 21(9):1550–1560\nMoney S (2017) Pathophysiology of trigger points in myofascial pain syndrome. J Pain Palliat Care Pharmacother 31(2):158–159\nMorrison T, Dmitrieva N, Winnard KP, Berkley KJ (2006) Opposing viscerovisceral effects of surgically induced endometriosis and a control abdominal surgery on the rat bladder. Fertil Steril 86:1067–1073\nMunakata J, Naliboff B, Harraf F, Kodner A, Lembo T, Chang L, Silverman DH, Mayer EA (1997) Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 112(1):55–63\nNicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, Cohen M, Evers S, Giamberardino MA, Goebel A, Korwisi B, Perrot S, Svensson P, Wang SJ, Treede RD, IASP taskforce for the classification of chronic pain (2019) The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain 160(1):28–37\nNierenburg Hdel C, Ailani J, Malloy M, Siavoshi S, Hu NN, Yusuf N (2015) Systematic review of preventive and acute treatment of menstrual migraine. Headache 55(8):1052–1071\nNunes FR, Ferreira JM, Bahamondes L (2014) Prevalence of fibromyalgia and quality of life in women with and without endometriosis. Gynecol Endocrinol 30:307–310\nNyholt DR, Gillespie NG, Merikangas KR, Treloar SA, Martin NG, Montgomery GW (2009) Common genetic influences underlie comorbidity of migraine and endometriosis. Genet Epidemiol 33(2):105–113\nOaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154:2310–2316\nOnder H, Hamamci M, Alpua M, Ulusoy EK (2019) Comorbid fibromyalgia in migraine patients: clinical significance and impact on daily life. Neurol Res 20:1–7\nPanerai AE, Vecchiet J, Panzeri P, Meroni P, Scarone S, Pizzigallo E, Giamberardino MA, Sacerdote P (2002) Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report. Clin J Pain 18(4):270–273\nPark JW, Cho Y-S, Lee SY, Kim E-S, Cho H, Shin HE, Suh GI, Choi M-G (2013) Concomitant functional gastrointestinal symptoms influence psychological status in Korean migraine patients. Gut Liver 7(6):668–674\nParthasarathy S, Sundar S, Mishra G (2019) Assessment of predisposing factors in myofascial pain syndrome and the analgesic effect of trigger point injections—a primary therapeutic interventional clinical trial. Indian J Anaesth 63(4):300–303\nPezzone MA, Liang R, Fraser MO (2005) A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology 128:1953–1964\nPodichetty VK, Mazanec DJ, Biscup RS (2003) Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention. Postgrad Med J 79:627–633\nPomes LM, Guglielmetti M, Bertamino E, Simmaco M, Borro M, Martelletti P (2019) Optimising migraine treatment: from drug–drug interactions to personalized medicine. J Headache Pain 20(1):56\nProcacci P, Zoppi M, Maresca M (1986) Clinical approach to visceral sensation. In: Cervero F, Morrison JFB (eds) Visceral sensation. Progress in brain research. Elsevier, Amsterdam, pp 21–28\nQin C, Malykhina AP, Thompson AM, Farber JP, Foreman RD (2010) Cross-organ sensitization of thoracic spinal neurons receiving noxious cardiac input in rats with gastroesophageal reflux. Am J Physiol Gastrointest Liver Physiol 298:934–942\nReeves JL, Jaeger B, Graff-Radford A (1986) Reliability of the pressure algometer as a measure of myofascial trigger point sensitivity. Pain 24:313–321\nRist PM, Tzourio C, Kurth T (2011) Associations between lipid levels and migraine: cross-sectional analysis in the epidemiology of vascular ageing study. Cephalalgia 31(14):1459–1465\nRodríguez-Osorio X, Sobrino T, Brea D, Martínez F, Leira CJ (2012) Endothelial progenitor cells: a new key for endothelial dysfunction in migraine. Neurology 79(5):474–479\nSacco S, Ricci S, Carolei A (2011) Tension-type headache and systemic medical disorders. Curr Pain Headache Rep 15:438–443\nSacco S, Ornello R, Ripa P, Tiseo C, Degan D, Pistoia F, Carolei A (2015) Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. Eur J Neurol 22(6):1001–1011\nSaggini R, Bellomo RG, Affaitati G, Lapenna D, Giamberardino MA (2007) Sensory and biomechanical characterization of two painful syndromes in the heel. J Pain 8(3):215–222\nSandner P, Tinel H, Affaitati G, Costantini R, Giamberardino MA (2015) Effects of PDE5 inhibitors and sGC stimulators in a rat model of artificial ureteral calculosis. PLoS One 10(10):e0141477\nSasmaz Mİ, Kirpat V (2019) The relationship between the severity of pain and stone size, hydronephrosis and laboratory parameters in renal colic attack. Am J Emerg Med. https://doi.org/10.1016/j.ajem.2019.06.013. (Epub ahead of print)\nSchmidt-Hansen PT, Svensson P, Bendtsen L, Graven-Nielsen T, Bach FW (2007) Increased muscle pain sensitivity in patients with tension-type headache. Pain 129:113–121\nScott NA, Guo B, Barton PM, Gerwin RD (2009) Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med 10(1):54–69\nScripter C (2018) Headache: tension-type headache. FP Essent 473:17–20\nSengupta JN (2009) Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol 194:131–174\nSerra J, Collado A, Solà R, Antonelli F, Torres X, Salgueiro M, Quiles C, Bostock H (2014) Hyperexcitable C nociceptors in fibromyalgia. Ann Neurol 75:196–208\nShah JP, Phillips TM, Danoff JV, Gerber LH (2005) A in vivo microanalytical technique for measuring the local biochemical mileu of human skeletal muscle. J Appl Physiol 99:1977–1984\nShimomura T, Kowa H, Nakano T, Kitano A, Marukawa H, Urakami K, Takahashi K (1994) Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 14(3):215–218\nSimons DG (1990) Muscular pain syndromes. Adv Pain Res Ther 17:1–41\nSimons DG (2008) New views of myofascial trigger points: etiology and diagnosis. Arch Phys Med Rehabil 89(1):157–159\nSimons DG, Travell JG, Simons LS (1999) Upper half of body. In: Travell & Simons’ myofascial pain and dysfunction. The trigger point manual, 2nd edn, vol 1. Williams & Wilkins, Baltimore, p 1038\nSlade GD, Sanders AE, Bair E, Brownstein N, Dampier D, Knott C, Fillingim R, Maixner WO, Smith S, Greenspan J, Dubner R, Ohrbach R (2013) Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study. Pain 154:750–760\nSrbely JZ (2010) New trends in the treatment and management of myofascial pain syndrome. Curr Pain Headache Rep 14:346–352\nStanford EJ, Dell JR, Parsons CL (2007) The emerging presence of interstitial cystitis in gynecologic patients with chronic pelvic pain. Urology 69:53–59\nStaud R (2007) Future perspectives: pathogenesis of chronic muscle pain. Best Pract Res Clin Rheumatol 21:581–596\nStaud R, Nagel S, Robinson ME, Price DD (2009) Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 145:96–104\nSteiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z (2018) Migraine is first cause of disability in under 50 s: will health politicians now take notice? J Headache Pain 19(1):17\nStickler GB (2005) Relationship between cyclic vomiting syndrome and migraine. Clin Pediatr (Phila) 44:505–508\nStisi S, Cazzola M, Buskila D, Spath M, Giamberardino MA, Sarzi-Puttini P, Arioli G, Alciati A, Leardini G, Gorla R, Marsico A, Ceccherelli F, Bazzichi L, Carignola R, Gracely RH, Salaffi F, Marinangeli F, Torta R, Di Franco M, Biasi G, Cassisi G, Casale R, Altomonte L, Atzeni F (2008) Italian fibromyalgia network. Etiopathogenetic mechanisms of fibromyalgia syndrome. Reumatismo 60(Suppl 1):25–35\nStovner LJ, Ægidius K, Linde M (2011) Endometriosis and headache. Curr Pain Headache Rep 15:415–419\nStratton P, Berkley KJ (2011) Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update 17(3):327–346\nTafuri E, Santovito D, de Nardis V, Marcantonio P, Paganelli C, Affaitati G, Bucci M, Mezzetti A, Giamberardino MA, Cipollone F (2015) MicroRNA profiling in migraine without aura: pilot study. Ann Med 47(6):468–473\nTana C, Tafuri E, Tana M, Martelletti P, Negro A, Affaitati G, Fabrizio A, Costantini R, Mezzetti A, Giamberardino MA (2013) New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? J Headache Pain 14:9\nTana C, Caulo M, Tafuri E, Di Vincenzo A, Tana M, De Angelis MV, Mezzetti A, Giamberardino MA (2014) Teaching neuroimages: a dangerous complication of spontaneous intracranial hypotension. Neurology 82(11):e94–e95\nTana C, Santilli F, Martelletti P, di Vincenzo A, Cipollone F, Davì G, Giamberardino MA (2015) Correlation between migraine severity and cholesterol levels. Pain Pract 15(7):662–670\nTana C, Giamberardino MA, Cipollone F (2017) microRNA profiling in atherosclerosis, diabetes, and migraine. Ann Med 49(2):93–105\nTchivileva IE, Ohrbach R, Fillingim RB, Greenspan JD, Maixner W, Slade GD (2017) Temporal change in headache and its contribution to the risk of developing first-onset temporomandibular disorder in the orofacial pain: prospective Evaluation and Risk Assessment (OPPERA) study. Pain 158:120–129\nTervila L, Marttila P (1975) Headache as a symptom of endometriosis externa. Ann Chir Gynaecol Fenn 64(4):239–241\nTietjen GE, Bushnell CD, Herial NA, Utley C, White L, Hafeez F (2007) Endometriosis is associated with prevalence of comorbid conditions in migraine. Headache 47(7):1069–1078\nTough EA, White AR, Richards S, Campbell J (2007) Variability of criteria used to diagnose myofascial trigger point syndrome: evidence from a review of literature. Clin J Pain 23:276–286\nTreede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavandʼhomme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ (2019) Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 160(1):19–27\nTreloar SA, Bell TA, Nagle CM, Purdie DM, Green AC (2010) Early menstrual characteristics associated with subsequent diagnosis of endometriosis. Am J Obstet Gynecol 202(6):534 (e1–6)\nVecchiet L, Giamberardino MA, Dragani L, Albe-Fessard D (1989) Pain from renal/ureteral calculosis: evaluation of sensory thresholds in the lumbar area. Pain 36:289–295\nVecchiet L, Giamberardino MA, Dragani L, de Bigontina P, Albe-Fessard D (1990) Latent myofascial trigger points: changes in muscular and subcutaneous pain thresholds at trigger point and target level. J Ma Med 5:151–154\nVecchiet L, Giamberardino MA, Saggini R (1991) Myofascial pain syndromes: clinical and pathophysiological aspects. Clin J Pain 7(Suppl 1):S16–S22\nVecchiet L, Giamberardino MA, de Bigontina P (1992) Referred pain from viscera: when the symptom persists despite the extinction of the visceral focus. Adv Pain Res Ther 20:101–110\nVecchiet L, Montanari G, Pizzigallo E, Iezzi S, de Bigontina P, Dragani L, Vecchiet J, Giamberardino MA (1996) Sensory characterization of somatic parietal tissues in chronic fatigue syndrome. Neurosci Lett 208:117–120\nVecchiet L, Pizzigallo E, Lezzi S, Affaitati G, Vecchiet J, Giamberardino MA (1998) Differentiation of sensitivity in different tissues and its clinical significance. J Musculoske Pain 6(1):33–45\nVera-Portocarrero LP, Ossipov MH, King T, Porreca F (2008) Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan. Gastroenterology 135(4):1369–1378\nVij B, Whipple MO, Tepper SJ, Mohabbat AB, Stillman M, Vincent A (2015) Frequency of migraine headaches in patients with fibromyalgia. Headache 55:860–865\nWesselmann U, Czakanski PP, Affaitati G, Giamberardino MA (1998) Uterine inflammation as a noxious visceral stimulus: behavioral characterization in the rat. Neurosci Lett 246(2):73–76\nWilder-Smith CH, Robert-Yap J (2007) Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol 13(27):3699–3704\nWinnard KP, Dmitrieva N, Berkley KJ (2006) Cross-organ interactions between reproductive, gastrointestinal, and urinary tracts: modulation by estrous stage and involvement of the hypogastric nerve. Am J Physiol Regul Integr Comp Physiol 291:R1592–R1601\nWinsvold BS, Hagen K, Aamodt AH, Stovner LJ, Holmen J, Zwart JA (2011) Headache, migraine and cardiovascular risk factors: the HUNT study. Eur J Neurol 18(3):504–511\nWolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172\nWolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62:600–610\nWolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B (2016) 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 46(3):319–329\nXu YM, Ge HY, Arendt-Nielsen L (2010) Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain 11:1348–1355\nZohsel K, Hohmeister J, Oelkers-Ax R, Flor H, Hermann C (2006) Quantitative sensory testing in children with migraine: preliminary evidence for enhanced sensitivity to painful stimuli especially in girls. Pain 123:10–18\nAuthor information\nAuthors and Affiliations\nCorresponding author\nAdditional information\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nAbout this article\nCite this article\nAffaitati, G., Costantini, R., Tana, C. et al. Co-occurrence of pain syndromes. J Neural Transm 127, 625–646 (2020). https://doi.org/10.1007/s00702-019-02107-8\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s00702-019-02107-8","source_license":"public-domain-us","license_restricted":false}